HRT Financial’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-385,676
| Closed | -$3.36M | – | 3297 |
|
2023
Q1 | $3.36M | Buy |
385,676
+311,482
| +420% | +$2.72M | 0.04% | 369 |
|
2022
Q4 | $465K | Buy |
+74,194
| New | +$465K | 0.01% | 1368 |
|
2021
Q4 | – | Sell |
-51,853
| Closed | -$189K | – | 3980 |
|
2021
Q3 | $189K | Buy |
+51,853
| New | +$189K | ﹤0.01% | 2452 |
|
2021
Q1 | – | Sell |
-104,393
| Closed | -$599K | – | 3062 |
|
2020
Q4 | $599K | Buy |
+104,393
| New | +$599K | 0.01% | 879 |
|
2020
Q3 | – | Sell |
-13,864
| Closed | -$48K | – | 2361 |
|
2020
Q2 | $48K | Buy |
+13,864
| New | +$48K | ﹤0.01% | 1190 |
|
2019
Q4 | – | Sell |
-22,633
| Closed | -$115K | – | 1663 |
|
2019
Q3 | $115K | Buy |
+22,633
| New | +$115K | 0.01% | 1122 |
|
2018
Q4 | – | Sell |
-24,709
| Closed | -$273K | – | 730 |
|
2018
Q3 | $273K | Buy |
+24,709
| New | +$273K | 0.04% | 228 |
|